Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H McAllister

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Pharmacology, Biochemistry, and Behavior|September 1, 1990
Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxideK H McAllister
European Journal of Pharmacology|February 9, 1993
Antagonism of non-NMDA receptors inhibits handling-induced, strychnine-potentiated convulsionsK H McAllister
Psychopharmacology|March 1, 1997
A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibitionK H McAllister
European Journal of Pharmacology|January 28, 1992
N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in miceK H McAllister
Psychopharmacology|December 17, 1997
A time-activity baseline to measure pharmacological and non-pharmacological manipulations of PCP-induced activity in miceK H McAllister
European Journal of Pharmacology|October 31, 1996
The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in ratsK H McAllister
Psychopharmacology|July 10, 2001
The alpha 2 adrenoceptor antagonists RX 821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in ratsK H McAllister
Psychopharmacology|November 1, 1994
D-cycloserine enhances social behaviour in individually-housed mice in the resident-intruder testK H McAllister
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2022
When depression is difficult to treatR H McAllister-Williams
Evidence-Based Mental Health|August 2, 2008
Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et alR H McAllister-Williams
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Pharmacology, Biochemistry, and Behavior|September 1, 1990
Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxideK H McAllister
European Journal of Pharmacology|February 9, 1993
Antagonism of non-NMDA receptors inhibits handling-induced, strychnine-potentiated convulsionsK H McAllister
Psychopharmacology|March 1, 1997
A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibitionK H McAllister
European Journal of Pharmacology|January 28, 1992
N-methyl-D-aspartate receptor antagonists and channel blockers have different effects upon a spinal seizure model in miceK H McAllister
Psychopharmacology|December 17, 1997
A time-activity baseline to measure pharmacological and non-pharmacological manipulations of PCP-induced activity in miceK H McAllister
European Journal of Pharmacology|October 31, 1996
The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in ratsK H McAllister
Psychopharmacology|July 10, 2001
The alpha 2 adrenoceptor antagonists RX 821002 and yohimbine delay-dependently impair choice accuracy in a delayed non-matching-to-position task in ratsK H McAllister
Psychopharmacology|November 1, 1994
D-cycloserine enhances social behaviour in individually-housed mice in the resident-intruder testK H McAllister
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2022
When depression is difficult to treatR H McAllister-Williams
Evidence-Based Mental Health|August 2, 2008
Do antidepressants work? A commentary on "Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration" by Kirsch et alR H McAllister-Williams
Pageof 14